GB2315674A - Mammalian foodstuff - Google Patents

Mammalian foodstuff Download PDF

Info

Publication number
GB2315674A
GB2315674A GB9716036A GB9716036A GB2315674A GB 2315674 A GB2315674 A GB 2315674A GB 9716036 A GB9716036 A GB 9716036A GB 9716036 A GB9716036 A GB 9716036A GB 2315674 A GB2315674 A GB 2315674A
Authority
GB
United Kingdom
Prior art keywords
food
feather meal
ingredient
supplement
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9716036A
Other versions
GB9716036D0 (en
GB2315674B (en
Inventor
Richard John Cleeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9616211.0A external-priority patent/GB9616211D0/en
Application filed by Individual filed Critical Individual
Priority to GB9716036A priority Critical patent/GB2315674B/en
Publication of GB9716036D0 publication Critical patent/GB9716036D0/en
Publication of GB2315674A publication Critical patent/GB2315674A/en
Application granted granted Critical
Publication of GB2315674B publication Critical patent/GB2315674B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/10Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from hair, feathers, horn, skins, leather, bones, or the like
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A mammalian food, food ingredient or a food supplement including hydrolysed feather meal for use in supplementing an adult mammal's feed at a daily rate of at least 0.5gm per 1kg live body weight or at at least 30% of the mammal's daily protein requirement.

Description

MAMMALIAN FOODSTUFF Field of the Invention The present invention relates to a food ingredient or supplement for mammals in particular but not exclusively non-ruminants.
Background of the invention It is recognised that sulphur containing organic compounds can have a beneficial effect as a food supplement.
Both naturally and artificially produced such substances have been marketed for their therapeutic effects. Examples of these substances are shark cartilage, chondroitin sulphate, glucosamine and methylsulphonylmethane (MSM) products.
Hydrolysed feather meal is currently fed in small concentrations as a protein additive or ingredient in animal foodstuffs.
The Invention The invention results from the recognition that hydrolysed feather meal includes sulphur containing organic compounds and that these compounds might provide similar benefits to those provided by the products mentioned above, particularly in cartilage synthesis and maintenance ofjoint integrity. Work in this field has not suggested that dietary supplementation with high rates of hydrolysed feather meal would benefit joint integrity. It is not generally considered that the necessary nutrients, in good but normal diets, are limiting to joint metabolism.
However tests have indicated that this supplementation has specific benefit in this regard.
The invention resides in the feeding of hydrolysed feather meal at higher rate than previously and specifically for its therapeutic effects.
According to the invention there is provided a food, food ingredient or a food supplement including hydrolysed feather meal for use in supplementing an adult mammal's feed at a daily rate of at least 0.5gm per lkg live body weight or at at least 30% of the mammal's daily protein requirement.
According to another aspect ofthe invention there is provided a medical ingredient or supplement of an adult mammal's feed for relieving arthritic and cartilage damage symptoms including hydrolysed feather meal for use in supplementing an animal's feed at a rate of at least 0.5gm per lkg live body weight or at at least 30% of the mammal's daily protein requirement.
Preferably the food, ingredient or supplement will be fed in combination with carbohydrate foodstuff and additional protein foodstuff, the additional protein foodstuff providing between 0% and 40% of the mammal's daily protein requirement.
In the preferred food the additional protein foodstuff provides between 30% and 40% ofthe mammal's daily protein requirement. That is to say, the hydrolysed feather meal is fed at a rate of 60 - 70% of protein requirement is expected. However feeding at up to 100% is acceptable.
The food can include of the order of 1 part of molasses for every 4 parts of hydrolysed feather meal. Further, it can contain of the order of 1 part of absorbent material for every 4 parts of hydrolysed feather meal. Preferably the absorbent material is bentonite.
Whilst the invention is intended for use in supplementing an animal's feed, in particular a dog's feed, it is anticipated that in a suitably palatable form, the supplement would be suitable for relieving arthritic symptoms in other animals and indeed humans.
It should be noted that a growing mammal has a higher protein requirement.
Higher feather meal feeding rates are required to provide an equivalent % of the daily protein requirement. However feeding for arthritic damage in a juvenile is unlikely to be required.
To help understanding of the invention, certain aspects of the bio-chemistry of mammalian joints, the composition of hydrolysed feather meal, and exemplary supplementation of a dog's feed with hydrolysed feather meal with a view to relief of joint deterioration will now be described.
Certain Aspects of the Biochemistry of Mammalian Joints Joints between the bones subject to endochondral ossification, e.g. those of the vertebral column and limbs, are the result of a very complex process of development that involves the interaction of several different tissues. The two ends of each bone develop and grow by a mechanism in which the growing cartilage is replaced with bone in the process of endochondral ossification, which means the replacement of cartilage by ossified cartilage and then by true bone.
Hyaline cartilage is composed of two principal structures, giving it flexible characteristics: proteoglycan aggregates of which there are at least five types - the largest being aggrecan and collagen. Collagen is the principal protein in white fibrous connective tissue. The proteoglycan aggregates are complex branched chains of hyaluronic acid, chondroitin sulphate and keratan sulphate together with a link protein and a core protein. Errors, some caused by malnutrition, in the development and growth of cartilage are precursors of poor quality bone. In turn that bone is subject to the effects of dietary failings. Bone is in a continuous state of metabolic flux throughout adult life, so that nutrient intake and hormonal balance continue to influence bone integrity. Failings in dietary adequacy throughout these times increase the risk of bone pain and arthritis.
Chondroitin sulphate is the major sulphated glycosaminoglycan present in the extra-cellular matrix of soft connective tissue (i). Hyaline cartilage contains at least five proteoglycans in its extra-cellular matrix. The largest is aggrecan, containing over 100 chondroitin sulphate and keratan sulphate chains. Chondroitin is a chain of repeating disacchride units, each composed of: [Glucuronic acid--N-acetylgalactosamine sulphate]n.
This compound contains approximately 7.2% sulphur. The fact that this unit is composed of two different sub-units, one of which is an amino sugar, makes the compound a mucopolysaccharide.
Aggrecan interacts with hyaluronic acid forming large proteoglycan aggregates.
Like chondroitin sulphate, hyaluronic acid is another mucopolysaccharide in which the repeating disaccharide units are: [Glucuronic acid--N-acetylglucosamine]n (ii).
This compound is a polymer, which is believed to be a core molecule. Itself, it is unsulphated, but the chondroitin sulphate and keratan sulphate chains form branches from the core molecule.
The sulphated glycosaminoglycan chains confer on those chains an ionic charge and they exhibit osmotic properties giving the articulation its ability to resist compressive loads. The loss of this "rubbery" reaction is believed to contribute to the damage associated with arthritis.
The remaining proteoglycans of cartilage are also characterized by their ability to interact with collagen. These proteoglycans, decorin, biglycan and fibromodulin are closely related in protein structure, but differ in glycosaminoglycan composition and function. Decorin and biglycan possess orie and two dermatan sulphate chains, respectively, whereas fibromodulin bears several keratan sulphate chains. Decorin and fibromodulin both interact with type II collagen fibrils in the matrix. Biglycan is localized, preferentially, where it may interact with type VI collagen (ii).
The glycosaminoglycan content of cartilage is reduced in osteoarthritis, where it is partially replaced by water, owing to damage incurred by the collagen network.
This can no longer restrain the swelling pressure of the glycosaminoglycan (iii). In juvenile rheumatoid arthritis and in adult rheumatoid arthritis the diseased synovial fluid also contains less glycosaminoglycan, therefore are lower concentrations of hyaluronic acid and of chondroitin 6-sulphate (iv). Chondroitin 6-sulphate is the normal adult form of this molecule, whereas in juvenile and arthrosic cartilage a mixture of 4-sulphate and 6-sulphate disaccharide units have been identified. Recent evidence points to chondroitin sulphate acting as a cross linking agent that stabilises the N-terminal portion of TSG-6 of the hyaluronan binding protein complex (v).
Thus cartilage is a combination of protein chains and chains of hexose units in disaccharide pairs that are richly sulphated. Structural damage to this tissue takes several forms.
It has been recently demonstrated that loss of antioxidant status, and the metabolic stress that results, with extensive free radical formation, are critical to the development of arthritis. It is possible that sulphur containing compounds, such as MSM and methionine, act in the joint as anti-oxidants, breaking chain reactions and so quenching the generation of free-radicals.
It should also be noted that copper is an important component of antioxidant enzymes, some of which have been demonstrated to be important in the control of arthritis.
Composition of Hvdrolvsed Feather Meal Feather meal is a product obtained by hydrolizing, drying and grinding poultry feathers. The processing involves pressure cooking, where cooking for 50-60 minutes at 140"-1500C (2.8-3.55kg/cm2) results in the best product. Feather meal is a good source of natural sulphur compounds.
Table 1. Sulphur composition of feather meal determined by chemical analysis.
% of feather meal Total feather meal sulphur 1.980 Total amino acid sulphur 1.127 Total non-amino acid sulphur 0.853 The non-amino acid sources of sulphur include chondroitin sulphate, dermatan sulphate and keratan sulphate, each of about 71/4% sulphur.
Feather meal and cartilage also contain sugar amines. It is these molecules to which the sulphur is attached and the amines are therefore present in dermatan, keratan, chondroitin and also in hyaluronic acid. Keratan contains N-acetylglucosamine-S and galactose; and chondroitin and dermatan contain N-acetylgalactosamine sulphate. Dilute HC1 hydrolysis of feather meal shows that it contains 8gm/kg of galactose. The digestion of proteoglycans in the canine intestine is little understood, so that their relevance to cartilage and bone structure maintenance must be speculative. Nevertheless the sulphur content is likely to be well utilised for proteoglycan maintenance in canine cartilage.
Comparison has been made of hydrolysed feather meal with other protein sources.
Fish meal is considered to be one of the highest quality animal proteins and soyabean meal one of the highest quality vegetable proteins for animal feeding. The feather meal, however, contains nearly twice as much methionine plus cystine as is contained in fish meal and it contains 3.3 times as much as is found in typical soyabean meal.
Table 2. Composition of animal and vegetable protein sources for comparison with hydrolysed feather meal, given as % of product (copper as mglkg).
Feather Meal Fish Meal Soyabean Meal /0 % o/O Dry Matter 90 92 90 Crude Protein 83.5 60 44 Fat 2.5 10 1 Crude Fibre 1.5 - 7 Ash 2.5 19.0 6 Calcium 0.2 5.0 0.25 Phosphorus 0.75 3.0 0.60 Copper,mg/kg 8 6.5 17 Lysine 1.87 4.57 2.73 Methionine 0.43 1.57 0.59 Methionine and Cystine 4.17 2.14 1.26 Threonine 3.86 2.44 1.72 Tryptophan 0.4 0.62 0.59 Gross Energy, MJ/kg 21.1 18.7 17.6 ME poultry, MJ/kg 9.8 12.3 8.9 The chemical analytical procedure for feather meal used a mild acid hydrolysis and so released amino acids that should be largely available to a dog. The ME content of feather meal suggests that it is quite well utilized, as the difference from fish meal could in large part be accounted for by the high fat content of fish meal. Thus the sulphur compounds of the two sources are likely to have equivalent digestibilities.
Exemplary Supplementation of a Dog's Feed with Hvdrolvsed Feather Meal with a view to Relief of Joint Deterioration Sulphur, in the form of S-containing amino acids, biotin, heparin, thiamin, insulin, and chondroitin sulphate, makes up about 0.15% of the dog's body weight, i.e.
30gm of a 20kg dog. The diet of this dog should contain daily about 0.75gm of sulphur in organic form. Many adult dogs receive a diet, relatively low in sulphuramino acid content. The integument (keratin of the skin, hair and claws) of the dog is rich in S-amino acids. It has been known for many years that dietary supplementation with inorganic sulphur is of no benefit in protein synthesis of non-ruminants. The dog must meet its S-amino acid requirements from organic sulphur sources for at least cysteine, cystine and methionine. These amino acids are components of the proteins of cartilage in joints. (Nevertheless, it should be noted that inorganic sources of sulphur can be utilized by a dog in the synthesis of chondroitin sulphate, and heparin).
The feeding of 40gm of feather meal daily would provide 130mg of methionine and 1580mg of cystine, i.e. a total of 1700mg of S-amino acids daily. A 20kg adult dog requires about 600mg of S-amino acids daily and a growing dog of the same breed, at about 10kg body weight, requires about 2100mg daily.
Feather meal is also a reasonable source of available copper. Excessive quantities of this element would be hazardous, but the amount in 20gm of feather meal should be helpful.
Observational studies indicate that daily supplements of 20-30gm of hydrolysed feather meal given to adult dogs has benefit for maintaining the mobility ofjoints.
A practical formulation of the hydrolysed feather meal as a dog food ingredient comprises 80% of the meal with 20% of molasses for palatability. To this can be added other supplements, such as vitamins, minerals and other chemical substances.
For instance additional vitamin D, copper and calcium is likely to be advantageous.
Since the feather meal is liable to cause the dog to produce foul smelling anal wind, containing hydrogen sulphide, I prefer to incorporate an absorbent material such as charcoal or in particular bentonite at a rate of 20% by weight.
Whilst the equivalent of 0.Sgm of the feather meal constituent per 1kg live body weight is the minimum recommended rate, I prefer to feed at double this rate.
This will provide 60-70% of the dog's daily protein requirement. The balance should be made up from conventional dog food, including meat and biscuit for carbohydrate.
References: (i) Worral et al., 1994 (ii) Roughley and Lee, 1994 (iii) Venn and Maroudas, 1977 (iv) Spelling et al., 1991 (v) Wisniewski et al. 1994.

Claims (7)

CLAIMS:
1. A mammalian food, food ingredient or a food supplement including hydrolysed feather meal for use in supplementing an adult mammal's feed at a daily rate of at least 0.5gm per lkg live body weight or at at least 30% of the mammal's daily protein requirement.
2. A medical ingredient or supplement of an adult mammal's feed hydrolysed feather meal for relieving arthritic and cartilage damage symptoms including for use in supplementing an animal's feed at a rate of at least 0.5gum per 1kg live body weight or at at least 30% ofthe mammal's daily protein requirement.
3. A food, ingredient or supplement as claimed in claim I or claim 2, in combination with carbohydrate foodstuff and additional protein foodstuff, the additional protein foodstuff providing between 0% and 40% of the mammal's daily protein requirement.
4. A food, ingredient or supplement as claimed in claim 3, wherein the additional protein foodstuff provides between 30% and 40% ofthe mammal's daily protein requirement.
5. A food, ingredient or supplement as claimed in any preceding claim, including of the order of 1 part of molasses for every 4 parts of hydrolysed feather meal.
6. A food, ingredient or supplement as claimed in any preceding claim, including of the order of 1 part of absorbent material for every 4 parts of hydrolysed feather meal.
7. A food, ingredient or supplement as claimed in claim 6, wherein the absorbent material is bentonite.
GB9716036A 1996-08-01 1997-07-30 Mammalian foodstuff Expired - Fee Related GB2315674B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9716036A GB2315674B (en) 1996-08-01 1997-07-30 Mammalian foodstuff

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616211.0A GB9616211D0 (en) 1996-08-01 1996-08-01 Mammalian foodstuff
GB9716036A GB2315674B (en) 1996-08-01 1997-07-30 Mammalian foodstuff

Publications (3)

Publication Number Publication Date
GB9716036D0 GB9716036D0 (en) 1997-10-01
GB2315674A true GB2315674A (en) 1998-02-11
GB2315674B GB2315674B (en) 2000-06-21

Family

ID=26309793

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9716036A Expired - Fee Related GB2315674B (en) 1996-08-01 1997-07-30 Mammalian foodstuff

Country Status (1)

Country Link
GB (1) GB2315674B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983766A1 (en) * 1999-01-20 2000-03-08 Norbert A. Gschwend A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
WO2002028400A1 (en) * 2000-10-03 2002-04-11 Nutraceutics Limited A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese
WO2005006878A1 (en) * 2003-07-07 2005-01-27 Hill's Pet Nutrition, Inc. Compositions for improved oxidative status in companion animals
WO2014202772A1 (en) * 2013-06-20 2014-12-24 Mars, Incorporated Performance pet food product
US9943089B2 (en) 2011-11-07 2018-04-17 Mars, Incorporated Food protein ingredient and methods for producing
WO2018222620A1 (en) * 2017-05-30 2018-12-06 Mars, Incorporated Methods for producing feather-based food products

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000084A1 (en) * 1978-12-11 1982-01-21 Bartz As Stord Method and apparatus for hydrolyzing keratin a ceous material
GB2112620A (en) * 1981-05-12 1983-07-27 Niels Werner Fritz Ockens A feedstuff for animals, especially dogs
JPS59220167A (en) * 1983-05-31 1984-12-11 Fumio Nishikawa Preparation of feather meal having good taste
SU1397018A1 (en) * 1986-02-14 1988-05-23 Всесоюзный Научно-Исследовательский Институт Мясной Промышленности Method of processing keratin-containing raw material for feed to animals
WO1989008990A1 (en) * 1988-03-31 1989-10-05 North Carolina State University Feather-lysate, a hydrolyzed feather feed ingredient and animal feeds containing the same
WO1992016114A1 (en) * 1991-03-12 1992-10-01 Kemp, Heath, Susan Animal feed containing molasses, bentonite and zeolite

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000084A1 (en) * 1978-12-11 1982-01-21 Bartz As Stord Method and apparatus for hydrolyzing keratin a ceous material
GB2112620A (en) * 1981-05-12 1983-07-27 Niels Werner Fritz Ockens A feedstuff for animals, especially dogs
JPS59220167A (en) * 1983-05-31 1984-12-11 Fumio Nishikawa Preparation of feather meal having good taste
SU1397018A1 (en) * 1986-02-14 1988-05-23 Всесоюзный Научно-Исследовательский Институт Мясной Промышленности Method of processing keratin-containing raw material for feed to animals
WO1989008990A1 (en) * 1988-03-31 1989-10-05 North Carolina State University Feather-lysate, a hydrolyzed feather feed ingredient and animal feeds containing the same
WO1992016114A1 (en) * 1991-03-12 1992-10-01 Kemp, Heath, Susan Animal feed containing molasses, bentonite and zeolite

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CAPLUS Abstract No. 121:132873 & J. Dairy Sci. (1994), 77(6)pages 1630-43 *
CAPLUS Abstract No. 124:287877 & Anim. Feed Sci. Technol. (1996) 57(1-2) pages 15-24 *
CAPLUS Abstract No. 87:51971 & Dtsch. Tieraerztl. Wochenschr(1977), 84(5) pages 180-5 *
WPI Abstract Acc. No. 85:023357 & JP 59-220167 (YAMA) *
WPI Abstract Acc. No. 88:344732 & SU 1397018 (CHERNAUKHA) *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983766A1 (en) * 1999-01-20 2000-03-08 Norbert A. Gschwend A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
WO2000043021A1 (en) * 1999-01-20 2000-07-27 Gschwend Norbert A Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt
WO2002028400A1 (en) * 2000-10-03 2002-04-11 Nutraceutics Limited A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese
US8835497B2 (en) 2003-07-03 2014-09-16 Hill's Pet Nutrition, Inc. Compositions for improved oxidative status in companion animals
WO2005006878A1 (en) * 2003-07-07 2005-01-27 Hill's Pet Nutrition, Inc. Compositions for improved oxidative status in companion animals
US9943089B2 (en) 2011-11-07 2018-04-17 Mars, Incorporated Food protein ingredient and methods for producing
AU2014283182B2 (en) * 2013-06-20 2017-11-23 Mars, Incorporated Performance pet food product
JP2016526379A (en) * 2013-06-20 2016-09-05 マース インコーポレーテッドMars Incorporated Performance pet food
CN105338825A (en) * 2013-06-20 2016-02-17 马斯公司 Performance pet food product
AU2014283182B9 (en) * 2013-06-20 2018-01-04 Mars, Incorporated Performance pet food product
WO2014202772A1 (en) * 2013-06-20 2014-12-24 Mars, Incorporated Performance pet food product
US10420783B2 (en) 2013-06-20 2019-09-24 Mars, Incorporated Performance food product
EP3632214A1 (en) * 2013-06-20 2020-04-08 Mars, Incorporated Performance pet food product
CN105338825B (en) * 2013-06-20 2020-05-22 马斯公司 Performance pet food
US10980823B2 (en) 2013-06-20 2021-04-20 Mars, Incorporated Performance food product
WO2018222620A1 (en) * 2017-05-30 2018-12-06 Mars, Incorporated Methods for producing feather-based food products
JP2020522232A (en) * 2017-05-30 2020-07-30 マース インコーポレーテッドMars Incorporated Manufacturing method of foods made from feathers
RU2766580C2 (en) * 2017-05-30 2022-03-15 Марс, Инкорпорейтед Methods of producing feather-based food products

Also Published As

Publication number Publication date
GB9716036D0 (en) 1997-10-01
GB2315674B (en) 2000-06-21

Similar Documents

Publication Publication Date Title
US8703174B2 (en) Joint preserving nutritional vitamin, mineral and herbal pet supplement
Carlisle In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick
CN1087152C (en) Nutritive composition
Si et al. Extent to which crude protein may be reduced in corn-soybean meal broiler diets through amino acid supplementation
CA2435392C (en) Desiccated avian sternal cartilage powder
BR9900973A (en) Concentration of glycosaminoglycans and precursors thereof in food products
CN101282731A (en) Composition and method for use in cartilage affecting conditions
Langar et al. Augmentation of protein synthesis and degradation by poor dietary amino acid balance in European sea bass (Dicentrarchus labrax)
CN101720928A (en) Combination for preventing and curing degenerative disease of bone and joint
CN111938037A (en) Dog food for promoting muscle growth and improving joint health and preparation method thereof
Zaloga et al. Effect of enteral diets on whole body and gut growth in unstressed rats
GB2315674A (en) Mammalian foodstuff
CN112205535A (en) Special nutritional food beneficial for weight loss of obese sterilized cats and preparation method thereof
JP2022534861A (en) dietary supplements for recovery
EP1118332B1 (en) A composition for treating degenerative joint diseases
Agunbiade et al. Performance characteristics of weaner rabbits on cassava peel-based balanced diets
ZA200606419B (en) Glycine and/or proline for use in cartilage affecting conditions
EP1408988B1 (en) Compositions of orally administered nutritional supplements to repair articular cartilage
Hidehisa et al. Protein and energy utilization of growing rats fed on the diets containing intact or partially hydrolyzed guar gum
CA2553748C (en) Composition and method for use in cartilage affecting conditions
Emery et al. Different patterns of protein turnover in skeletal and gastrointestinal smooth muscle and the production of Nτ-methylhistidine during fasting in the rat
US7214666B1 (en) Composition of orally administered nutritional supplements to repair articular cartilage
Bailey The collagen of the echinodermata
Agunbiade et al. African yam bean hull chemical composition and its effects on rat′ s mineral retention, serum biochemical components and enzymatic activities
Warriss The chemical composition and structure of meat.

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20020730